Graf Akcie NXGN (NextGen Healthcare Inc). Diskuze k akciím NXGN. Aktuální informace NXGN.

Základní informace o společnosti NextGen Healthcare Inc (Akcie NXGN)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 967.56M
Hodnota podniku (EV) 934.19M
Tržby 572.026M
EBITDA 60.305M
Zisk 13.187M
Růst v tržbách Q/Q 11.62 %
Růst v tržbách Y/Y 6.08 %
P/E (Cena vůči ziskům) 72.65
Forward P/E 69.86
EV/Sales 1.63
EV/EBITDA 15.49
EV/EBIT 63.92
PEG 2.35
Price/Sales 1.69
P/FCF 18.43
Price/Book 2.24
Účetní hodnota na akcii 6.48
Hotovost na akcii 1.18
FCF vůči ceně 5.43 %
Počet zaměstnanců 2,564
Tržba na zaměstnance 223.099k
Profit margin 1.71 %
Operating margin 2.57 %
Gross margin 50.54 %
EBIT margin 2.56 %
EBITDA margin 10.54 %
EPS - Zisk na akcii 0.20
EPS - Kvartální růst 19.05 %
EPS - Očekávaný růst příští rok -23.33 %
Return on assets 2.03 %
Return on equity 3.07 %
ROIC 1.88 %
ROCE 3.11 %
Dluhy/Equity 0.49
Čistý dluh/EBITDA -1.82
Current ratio 1.25
Quick Ratio 1.25
Volatilita 2.67
Beta 1.19
RSI 48.89
Cílová cena analytiků 15
Známka akcie (dle analytiků) 2.86
Insider ownership 19.30 %
Institutional ownership 79.37 %
Počet akcií 67.332M
Procento shortovaných akcií 4.19 %
Short ratio 6.37 %
Dividenda 0.00
Procentuální dividenda 0.00 %
Dividenda/Zisk 0.00 %
Obchodovaná od 1982
Země United States

Finanční výsledky akcie NXGN

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$540.239$529.173$531.019$509.624$492.477$490.225
Cost Of Goods Sold$267.439$246.697$241.535$223.134$225.615$223.164
Gross Profit$272.8$282.476$289.484$286.49$266.862$267.061
Research And Development Expenses$83.295$80.994$81.259$78.341$65.661$69.24
SG&A Expenses$165.174$164.879$193.226$163.623$156.234$158.172
Other Operating Income Or Expenses$-12.571-$-3.757---
Operating Expenses$535.127$497.554$528.198$482.611$485.115$454.269
Operating Income$5.112$31.619$2.821$27.013$7.362$35.956
Total Non-Operating Income/Expense$-0.853$-2.331$-3.231$-3.404$-1.042$-0.292
Pre-Tax Income$4.259$29.288$-0.41$23.609$6.32$35.664
Income Taxes$-3.239$4.794$-2.83$5.368$0.663$8.332
Income After Taxes$7.498$24.494$2.42$18.241$5.657$27.332
Other Income------
Income From Continuous Operations$7.498$24.494$2.42$18.241$5.657$27.332
Income From Discontinued Operations------
Net Income$7.498$24.494$2.42$18.241$5.657$27.332
EBITDA$66.186$75.461$48.584$68.523$69.597$65.223
EBIT$5.112$31.619$2.821$27.013$7.362$35.956
Basic Shares Outstanding656463626160
Shares Outstanding666563626161
Basic EPS$0.11$0.38$0.04$0.30$0.09$0.45
EPS - Earnings Per Share$0.11$0.38$0.04$0.29$0.09$0.45
# 2020 2019 2018 2017 2016 2015
Current Ratio1.81551.24661.05251.14071.33271.6506
Long-term Debt / Capital0.24360.02840.10270.04690.2805-
Debt/Equity Ratio0.32210.02930.11440.04920.3898-
Gross Margin50.496253.380754.514856.21654.187754.4772
Operating Margin0.94625.97520.53125.30061.49497.3346
EBIT Margin0.94625.97520.53125.30061.49497.3346
EBITDA Margin12.251214.26029.149213.445814.13213.3047
Pre-Tax Profit Margin0.78845.5347-0.07724.63261.28337.275
Net Profit Margin1.38794.62870.45573.57931.14875.5754
Asset Turnover0.75020.9931.02961.07690.92781.0645
Inventory Turnover Ratio--1341.8611412.24406.5135358.7846
Receiveable Turnover6.6815.80615.70475.91993.88594.4238
Days Sales In Receivables54.632562.86563.98261.65693.928382.5087
ROE - Return On Equity1.87226.51530.74835.97982.19.6396
Return On Tangible Equity9.928523.42137.94936.5317-50.803614.9945
ROA - Return On Assets1.04124.59640.46923.85461.06585.935
ROI - Return On Investment1.41616.33010.67155.69951.5119.6396
Book Value Per Share6.05585.79825.05374.88424.41764.7019
Operating Cash Flow Per Share0.5234-0.3858-0.60981.1107-0.6939-0.3702
Free Cash Flow Per Share0.5087-0.329-0.73241.25-0.8151-0.24